Cyanotech (NASDAQ:CYAN) Share Price Crosses Above 50 Day Moving Average of $2.47

Shares of Cyanotech Corp (NASDAQ:CYAN) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $2.47 and traded as high as $2.48. Cyanotech shares last traded at $2.51, with a volume of 4 shares changing hands.

The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 0.41. The business has a 50-day simple moving average of $2.47 and a 200-day simple moving average of $2.89.

Cyanotech (NASDAQ:CYAN) last posted its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $8.07 million during the quarter. Cyanotech had a negative net margin of 7.88% and a negative return on equity of 15.79%.

An institutional investor recently bought a new position in Cyanotech stock. Citadel Advisors LLC bought a new position in shares of Cyanotech Corp (NASDAQ:CYAN) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,811 shares of the biotechnology company’s stock, valued at approximately $49,000. Citadel Advisors LLC owned approximately 0.27% of Cyanotech as of its most recent filing with the SEC. Institutional investors own 12.83% of the company’s stock.

Cyanotech Company Profile (NASDAQ:CYAN)

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.

Featured Story: What is a capital gain?

Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.